CYH Community Health Systems, Inc. Common Stock
حول Community Health Systems, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
اقرأ المزيد
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
CYH لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
CYH مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 13 ديسمبر، 2012 | $0,2066 |
CYH توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 1 6,2%
- شراء 1 6,2%
- احتفاظ 6 37,5%
- بيع 7 43,8%
- بيع قوي 1 6,2%
السعر المستهدف لمدة 12 شهرًا
7 محللين · 2026-08-13سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.19 | $-0.06 | -0.13% |
| 31 مارس، 2026 | $-0.48 | $-0.10 | -0.38% |
| 31 ديسمبر، 2025 | $-0.01 | $-0.10 | 0.10% |
| 30 سبتمبر، 2025 | $1.27 | $-0.25 | 1.5% |
| 30 يونيو، 2025 | $-0.05 | $-0.11 | 0.06% |
| 31 مارس، 2025 | $-0.03 | $-0.08 | 0.05% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | — |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| USPH | — | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | — |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
الميزانية العمومية 26
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
التدفق النقدي 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
السيولة والملاءة 4
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
قائمة الدخل 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | -266,863,732 | 133,787,535 | 133,763,733 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -257,247,066 | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | -267,935,024 | 135,187,592 | 134,882,981 | 132,876,691 | -263,891,006 | 132,376,226 | 132,344,504 | 131,272,044 | -260,601,819 | 130,698,907 | 130,659,672 | 129,688,917 | -255,995,134 | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
الميزانية العمومية 25
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
التدفق النقدي 10
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
السيولة والملاءة 4
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
الكفاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.01B | $12.34B | · | $12.47B | $12.52B | $12.53B | · | $12.46B | $12.48B | $12.45B | · | $12.33B | $12.18B | $12.18B | · | $12.19B | |
| Net Income TTM | $424M | $341M | · | $8M | $-135M | $-458M | · | $-536M | $-183M | $-221M | · | $-222M | $-457M | $-420M | · | $-258M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.1 | 1.2 | · | · | -3.2 | -0.8 | · | -1.5 | -2.4 | -2.1 | · | -1.7 | -1.2 | -1.5 | · | -1.1 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| P / FCF | · | -1.1 | · | · | · | 10.8 | · | · | · | 162.1 | · | · | · | -5.7 | · | · | |
| EV / EBITDA | 25.4 | 35.0 | · | 44.9 | 21.2 | 39.6 | · | -59.9 | 50.1 | 51.8 | · | 70.1 | 49.6 | 58.2 | · | 58.5 | |
| EV / FCF | · | -26.4 | · | · | · | 321.5 | · | · | · | 3990.5 | · | · | · | -104.5 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 93.7% | 85.7% | · | 0.00% | -31.2% | -128.5% | · | -66.9% | -41.7% | -48.6% | · | -58.6% | -80.2% | -66.3% | · | -93.0% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| هامش الربح التشغيلي % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| صافي الدخل | $509M | $-516M | $-133M | $46M | $230M |
| EPS المخفف | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| النسبة الحالية | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| النسبة السريعة | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $208M | $120M | $-257M | $-115M | $-600M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 201 مقدم إقرار · $341.1M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 37 (+19 مقابل الربع السابق) | 24 (+4 مقابل الربع السابق) | 65 (+4 مقابل الربع السابق) | 49 (-12 مقابل الربع السابق) | +15.7M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| CastleKnight Management LP | $44704517 | 13384586 | 13,10% | الأسهم |
| Apollo Management Holdings, L.P. | $39610817 | 11859526 | 11,61% | الأسهم |
| Eversept Partners, LP | $26267680 | 7864575 | 7,70% | الأسهم |
| VANGUARD GROUP INC | $25789362 | 8265821 | 7,56% | الأسهم |
| NOMURA HOLDINGS INC | $22388384 | 6703109 | 6,56% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $17668370 | 5289931 | 5,18% | الأسهم |
| WHITEBOX ADVISORS LLC | $12467362 | 3732743 | 3,65% | الأسهم |
| STATE STREET CORP | $10226622 | 3061863 | 3,00% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10082117 | 3018598 | 2,96% | الأسهم |
| Saba Capital Management, L.P. | $9626444 | 2882169 | 2,82% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $9084165 | 2719143 | 2,66% | الأسهم |
| Owl Creek Asset Management, L.P. | $8452277 | 2530622 | 2,48% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8176380 | 2448018 | 2,40% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $7510531 | 2248662 | 2,20% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $7365822 | 2205336 | 2,16% | الأسهم |
| Diameter Capital Partners LP | $6138793 | 1837962 | 1,80% | الأسهم |
| TWO SIGMA ADVISERS, LP | $5816476 | 1864255 | 1,70% | الأسهم |
| CARRONADE CAPITAL MANAGEMENT, LP | $5230000 | 1565847 | 1,53% | الأسهم |
| Allianz Asset Management GmbH | $5167919 | 1547281 | 1,51% | الأسهم |
| D. E. Shaw & Co., Inc. | $4779143 | 1430881 | 1,40% | الأسهم |
| Silver Rock Financial LP | $3674000 | 1100000 | 1,08% | الأسهم |
| CITADEL ADVISORS LLC | $3177085 | 951223 | 0,93% | الأسهم |
| Assenagon Asset Management S.A. | $2788275 | 834813 | 0,82% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $2642231 | 791087 | 0,77% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $2566736 | 768484 | 0,75% | الأسهم |
| Jefferies Financial Group Inc. | $2481286 | 742900 | 0,73% | الأسهم |
| Alta Fundamental Advisers LLC | $2161411 | 647129 | 0,63% | الأسهم |
| GOLDMAN SACHS GROUP INC | $2016194 | 603651 | 0,59% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $1701580 | 509455 | 0,50% | الأسهم |
| ExodusPoint Capital Management, LP | $1664603 | 498384 | 0,49% | الأسهم |
| READYSTATE ASSET MANAGEMENT LP | $1657729 | 496326 | 0,49% | الأسهم |
| WOLVERINE ASSET MANAGEMENT LLC | $1339674 | 401100 | 0,39% | عقد خيار الشراء |
| Helix Partners Management LP | $1336000 | 400000 | 0,39% | الأسهم |
| Bank of New York Mellon Corp | $1325679 | 396910 | 0,39% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $1280940 | 383515 | 0,38% | الأسهم |
| Voleon Capital Management LP | $1247032 | 373363 | 0,37% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $999388 | 299218 | 0,29% | الأسهم |
| Pathstone Holdings, LLC | $895621 | 268150 | 0,26% | الأسهم |
| Prescott Group Capital Management, L.L.C. | $863076 | 258406 | 0,25% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $835000 | 250000 | 0,24% | عقد خيار البيع |
| FEDERATED HERMES, INC. | $812599 | 243293 | 0,24% | الأسهم |
| LPL Financial LLC | $737239 | 220730 | 0,22% | الأسهم |
| IEQ CAPITAL, LLC | $657963 | 196995 | 0,19% | الأسهم |
| RHUMBLINE ADVISERS | $543412 | 162701 | 0,16% | الأسهم |
| Nuveen, LLC | $535683 | 160384 | 0,16% | الأسهم |
| BOOTHBAY FUND MANAGEMENT, LLC | $506701 | 151707 | 0,15% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $501668 | 150200 | 0,15% | عقد خيار الشراء |
| Caption Management, LLC | $501000 | 150000 | 0,15% | عقد خيار الشراء |
| Nuveen Asset Management, LLC | $479548 | 160384 | 0,14% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $442056 | 132352 | 0,13% | الأسهم |
| DEUTSCHE BANK AG\ | $423131 | 126686 | 0,12% | الأسهم |
| State of Wyoming | $386675 | 115771 | 0,11% | الأسهم |
| CAHABA WEALTH MANAGEMENT, INC. | $367400 | 110000 | 0,11% | الأسهم |
| STRS OHIO | $334000 | 100000 | 0,10% | الأسهم |
| EQUITABLE TRUST CO | $334000 | 100000 | 0,10% | الأسهم |
| Turtle Creek Wealth Advisors, LLC | $334000 | 100000 | 0,10% | الأسهم |
| Parkwoods Wealth Partners, LLC | $330319 | 98898 | 0,10% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $322096 | 96436 | 0,09% | الأسهم |
| CITIGROUP INC | $321361 | 96216 | 0,09% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $311640 | 106000 | 0,09% | الأسهم |
| Lombard Odier Asset Management (USA) Corp | $297260 | 89000 | 0,09% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $287908 | 86200 | 0,08% | عقد خيار البيع |
| NorthCrest Asset Manangement, LLC | $283320 | 76573 | 0,08% | الأسهم |
| MetLife Investment Management, LLC | $278232 | 83303 | 0,08% | الأسهم |
| CITADEL ADVISORS LLC | $242818 | 72700 | 0,07% | عقد خيار البيع |
| LAZARD ASSET MANAGEMENT LLC | $240887 | 72122 | 0,07% | الأسهم |
| Cetera Investment Advisers | $223339 | 66868 | 0,07% | الأسهم |
| Mariner, LLC | $222538 | 66627 | 0,07% | الأسهم |
| Cerity Partners LLC | $211102 | 63204 | 0,06% | الأسهم |
| Apollon Wealth Management, LLC | $203453 | 60914 | 0,06% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $199755 | 59807 | 0,06% | الأسهم |
| JANE STREET GROUP, LLC | $179692 | 53800 | 0,05% | عقد خيار الشراء |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $176339 | 128756 | 0,05% | الأسهم |
| Invesco Ltd. | $171559 | 51365 | 0,05% | الأسهم |
| CITADEL ADVISORS LLC | $153640 | 46000 | 0,05% | عقد خيار الشراء |
| MERCER GLOBAL ADVISORS INC /ADV | $150911 | 45183 | 0,04% | الأسهم |
| Schonfeld Strategic Advisors LLC | $147660 | 44210 | 0,04% | الأسهم |
| Vanguard Global Advisers, LLC | $144134 | 43154 | 0,04% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $136659 | 40916 | 0,04% | الأسهم |
| Red Door Wealth Management, LLC | $130260 | 39000 | 0,04% | الأسهم |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $128810 | 38566 | 0,04% | الأسهم |
| BlackRock, Inc. | $126606 | 37906 | 0,04% | الأسهم |
| XTX Topco Ltd | $126098 | 37754 | 0,04% | الأسهم |
| GROUP ONE TRADING LLC | $123633 | 37016 | 0,04% | الأسهم |
| Bison Wealth, LLC | $121992 | 33150 | 0,04% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $116957 | 35017 | 0,03% | الأسهم |
| Nebula Research & Development LLC | $116025 | 34125 | 0,03% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $113724 | 34049 | 0,03% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $111419 | 33359 | 0,03% | الأسهم |
| Quantbot Technologies LP | $110450 | 33069 | 0,03% | الأسهم |
| WOLVERINE TRADING, LLC | $108016 | 34400 | 0,03% | عقد خيار الشراء |
| INTECH INVESTMENT MANAGEMENT LLC | $107535 | 32196 | 0,03% | الأسهم |
| Advisory Services Network, LLC | $105845 | 31690 | 0,03% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $105537 | 31598 | 0,03% | الأسهم |
| Independent Advisor Alliance | $99766 | 29870 | 0,03% | الأسهم |
| Callan Family Office, LLC | $96195 | 28801 | 0,03% | الأسهم |
| CAPTRUST FINANCIAL ADVISORS | $91736 | 27466 | 0,03% | الأسهم |
| Brevan Howard Capital Management LP | $91125 | 27283 | 0,03% | الأسهم |
| Atom Investors LP | $90527 | 27104 | 0,03% | الأسهم |
| Lakeview Capital Partners, LLC | $89580 | 29960 | 0,03% | الأسهم |
المطلعون على الشركة 57 من المطلعين · مسؤولون 29 · مديرون 23
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 1 مارس، 2026 A | 895545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 1 مارس، 2025 A | 1388781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 1 مارس، 2026 A | 268439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 7 ديسمبر، 2019 F | 241515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 1 مارس، 2017 A | 568152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 1 مارس، 2025 D | 47635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 1 مارس، 2025 A | 142500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 1 مارس، 2025 A | 128637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 1 مارس، 2025 A | 136815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 1 مارس، 2024 A | 58701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 1 مارس، 2024 A | 482657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 1 مارس، 2019 A | 62969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 1 مارس، 2019 F | 119017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 1 مارس، 2017 A | 41242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 1 مارس، 2017 A | 68649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 1 مارس، 2017 A | 100458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 1 مارس، 2017 A | 110156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 1 مارس، 2016 A | 112107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 1 مارس، 2016 A | 440840 | 0 | 0 | $0 |
| William S Hussey | Division President | 28 أكتوبر، 2015 M | 121568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 3 يونيو، 2015 M | 94111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 25 أغسطس، 2008 M | 118286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 1 يونيو، 2026 A | 30000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 1 مارس، 2026 A | 51736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 1 مارس، 2026 A | 287750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 1 مارس، 2026 A | 208290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 1 مارس، 2017 F | 243065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 25 فبراير، 2012 F | 78379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 1 مارس، 2006 A | 40354 | 0 | 0 | $0 |
| Ranga K Krishnan | مدير | 30 يونيو، 2026 M | 170023 | 0 | 0 | $0 |
| Fawn D Lopez | مدير | 1 مارس، 2026 A | — | 0 | 0 | $0 |
| Ronald L Burgess JR | مدير | 1 مارس، 2026 A | — | 0 | 0 | $0 |
| Susan W Brooks | مدير | 1 مارس، 2026 A | 108695 | 0 | 0 | $0 |
| Hubert James Williams | مدير | 1 مارس، 2026 A | 211863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | مدير | 1 مارس، 2026 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | مدير | 1 مارس، 2026 A | 162059 | 0 | 0 | $0 |
| James S. Ely III | مدير | 1 مارس، 2026 A | 412876 | 0 | 0 | $0 |
| William Norris Jennings | مدير | 1 مارس، 2026 A | 78468 | 0 | 0 | $0 |
| John A Fry | مدير | 1 مارس، 2026 A | 268966 | 0 | 0 | $0 |
| John A Clerico | مدير | 1 مارس، 2026 A | 368763 | 0 | 0 | $0 |
| Michael Dinkins | مدير | 1 مارس، 2026 A | 225882 | 0 | 0 | $0 |
| Wayne T Smith | مدير | 1 مارس، 2026 A | 5217579 | 0 | 0 | $0 |
| Julia B North | مدير | 1 مارس، 2021 A | 162056 | 0 | 0 | $0 |
| Mitchell H Watson JR | مدير | 16 مايو، 2017 M | 22594 | 0 | 0 | $0 |
| Harvey Klein MD | مدير | 15 مارس، 2010 M | 10383 | 0 | 0 | $0 |
| Dale F Frey | مدير | 31 مارس، 2008 A | 20000 | 0 | 0 | $0 |
| Thomas H Lister | مدير | 21 سبتمبر، 2004 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | مدير | 21 سبتمبر، 2004 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | مدير | 21 سبتمبر، 2004 S | 0 | 0 | 0 | $0 |
| Robert J Dole | مدير | 6 مايو، 2004 S | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 1 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 إيداعات | 11 مارس، 2021 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 36 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2,68% | 21287000 | 8 أغسطس، 2026 | يومي |
| EBIT · Harbor ETF Trust | 0,48% | 19323 NS | 30 إبريل، 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,35% | 1058000 PA | 8 أغسطس، 2026 | يومي |
| DFVE · DoubleLine ETF Trust | 0,20% | 18550 NS | 31 مارس، 2026 | N-PORT |
| IWC · iShares Trust | 0,09% | 441586 SH | 8 أغسطس، 2026 | يومي |
| IHF · iShares Trust | 0,06% | 232511 SH | 8 أغسطس، 2026 | يومي |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 132595 NS | 31 مايو، 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 113109 SH | 8 أغسطس، 2026 | يومي |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1304000 SH | 8 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 253747 SH | 8 أغسطس، 2026 | يومي |
| IWN · iShares Trust | 0,02% | 1218442 SH | 8 أغسطس، 2026 | يومي |
| IWM · iShares Trust | 0,01% | 3418265 SH | 8 أغسطس، 2026 | يومي |
| FNDX · SCHWAB STRATEGIC TRUST | 0,01% | 1126552 NS | 31 مايو، 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 56434 NS | 30 إبريل، 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 53684 NS | 31 مايو، 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 746733 SH | 8 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,01% | 349881 SH | 8 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,01% | 466961 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 6034 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 546576 NS | 31 مايو، 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 4719 NS | 31 مايو، 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4772 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 5006 NS | 31 مايو، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 120 NS | 31 مايو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 202789 NS | 30 إبريل، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 33838 NS | 30 إبريل، 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 203866 SH | 8 أغسطس، 2026 | يومي |
| IWV · iShares Trust | 0,00% | 41727 SH | 8 أغسطس، 2026 | يومي |
| DCOR · Dimensional ETF Trust | 0,00% | 6184 NS | 30 إبريل، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 31135 NS | 30 إبريل، 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 70316 NS | 31 مايو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1347195 SH | 8 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3813888 SH | 8 أغسطس، 2026 | يومي |
| VPLS · VANGUARD MALVERN FUNDS | 0,00% | 20000 PA | 8 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9817 SH | 8 أغسطس، 2026 | يومي |
| DFSU · Dimensional ETF Trust | 0,00% | 24 NS | 30 إبريل، 2026 | N-PORT |